hemophilia A - Nursing Case Study

Pathophysiology

• Primary mechanism: Hemophilia A is caused by a deficiency or dysfunction of clotting factor VIII, a critical protein in the intrinsic pathway of the coagulation cascade, leading to impaired thrombin generation and inadequate fibrin clot formation.

• Secondary mechanism: The absence of sufficient factor VIII disrupts the activation of factor X, preventing the conversion of prothrombin to thrombin, which is essential for producing a stable fibrin clot, thereby prolonging bleeding episodes.

• Key complication: Severe hemophilia A can result in spontaneous bleeding into joints and muscles, leading to hemarthrosis and potential joint destruction, highlighting the importance of managing and preventing bleeding to avoid long-term musculoskeletal damage.

Patient Profile

Demographics:

28-year-old male, construction worker

History:

• Key past medical history: Severe Hemophilia A diagnosed at age 2, recurrent joint bleeds, hepatitis C from blood transfusions

• Current medications: Factor VIII replacement therapy, Desmopressin, Hepatitis C antiviral therapy

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe abdominal pain and swelling

• Key symptoms: Extensive bruising, prolonged bleeding from minor cuts, severe joint pain, fatigue

• Vital signs: Blood pressure 88/60 mmHg, heart rate 128 bpm, respiratory rate 24 breaths per minute, temperature 100.4°F, oxygen saturation 92% on room air

Section 1

Initial Assessment Findings:

Upon initial examination, the patient presents with severe abdominal distension and tenderness upon palpation, suggestive of intra-abdominal bleeding. His skin exhibits extensive ecchymosis, and he reports persistent, severe pain in the right elbow and left knee, indicating potential hemarthrosis. The patient's mucous membranes appear pale, correlating with his reported fatigue and suggesting possible anemia secondary to chronic blood loss. Given his low blood pressure and elevated heart rate, there is a strong suspicion of hypovolemic shock, likely exacerbated by internal bleeding.

Laboratory results reveal a hemoglobin level of 6.8 g/dL and a hematocrit of 20%, confirming significant anemia. His platelet count is within normal limits, but his prothrombin time (PT) and activated partial thromboplastin time (aPTT) are markedly prolonged, consistent with severe hemophilia A and inadequate clotting factor replacement. Liver function tests show elevated transaminases, raising concerns about potential hepatic compromise, possibly exacerbated by his ongoing hepatitis C infection.

The patient's oxygen saturation remains suboptimal at 92% on room air, necessitating supplemental oxygen therapy. A decision is made to start an urgent transfusion of factor VIII concentrate and initiate IV fluid resuscitation to stabilize his hemodynamic status. The team is also considering the need for a CT scan to identify the exact source of intra-abdominal bleeding, while carefully weighing the risk of further bleeding associated with invasive diagnostic procedures. This complex presentation requires vigilant monitoring and precise adjustments to his treatment plan to prevent further deterioration and ensure timely intervention.

Section 2

As the medical team proceeds with the interventions, the patient is closely monitored for any changes in his condition. Despite the initial administration of factor VIII concentrate and IV fluids, his blood pressure remains critically low at 85/50 mmHg, and his heart rate persists at a tachycardic 125 beats per minute. Recognizing the need for further stabilization, the decision is made to administer additional units of packed red blood cells to address his anemia and improve oxygen delivery. Concurrently, the patient is placed on high-flow oxygen therapy, which improves his oxygen saturation to 95%.

Within a few hours, new diagnostic imaging results return, revealing a significant hematoma in the retroperitoneal space, confirming the source of the intra-abdominal bleeding. This finding complicates the clinical picture, as surgical intervention may be required to prevent further hemorrhage, but it carries significant risks given the patient's coagulopathy. The team must now consider the balance between surgical intervention and the potential for exacerbating the bleeding due to his underlying hemophilia A and inadequate clotting ability.

Meanwhile, the patient's liver function continues to decline, as evidenced by a rise in bilirubin to 3.5 mg/dL and further elevation of transaminases. This raises the suspicion of acute hepatic decompensation, potentially linked to his hepatitis C infection and compounded by the stress of his current condition. The worsening liver function could further compromise coagulation, necessitating a multidisciplinary approach involving hepatology. This situation demands a reassessment of his treatment plan, with a focus on optimizing clotting factor replacement, managing potential hepatic encephalopathy, and preparing for possible surgical intervention if the bleeding cannot be controlled through conservative measures. The complexity of these intertwined issues underscores the need for advanced critical thinking and vigilant, ongoing reassessment.

Section 3

As the medical team continues to navigate the complexities of the patient's condition, a notable change in his status is observed. Despite aggressive management, including additional factor VIII replacement and transfusion of packed red blood cells, the patient's blood pressure remains tenuously stable at 90/55 mmHg, and his heart rate hovers around 120 beats per minute. However, a new complication arises when the patient exhibits signs of altered mental status, including confusion and slight disorientation, raising concerns about potential cerebral hypoperfusion or the onset of hepatic encephalopathy given his liver dysfunction.

A repeat set of laboratory tests reveals further deterioration in his coagulation profile, with an INR climbing to 2.8 and aPTT extending beyond 60 seconds, indicating worsening coagulopathy. The patient's platelet count has also decreased to 75,000/mm³, adding to the bleeding risk. Concurrently, ammonia levels are elevated at 75 µmol/L, suggesting the early stages of hepatic encephalopathy. These findings necessitate an urgent consultation with hepatology to address the liver's deteriorating function and strategize the management of hepatic complications, including consideration of lactulose or rifaximin to mitigate encephalopathy symptoms.

In light of the patient's altered mental status and escalating coagulopathy, the medical team is faced with a critical decision point. The need for surgical intervention to address the retroperitoneal hematoma becomes increasingly pressing, yet the risks of operative bleeding are substantial. The team must weigh the potential benefits of a surgical approach against the likelihood of exacerbating his bleeding tendencies. As they deliberate, a comprehensive plan must be developed that incorporates rigorous hemodynamic monitoring, ongoing liver support, and meticulous adjustment of clotting factor replacement to navigate this precarious clinical landscape.

Section 4

As the medical team continues to grapple with the complexities of the patient's condition, a new and concerning change in status emerges. Overnight, the patient develops signs of acute respiratory distress, characterized by increased work of breathing, use of accessory muscles, and an oxygen saturation dropping to 85% on high-flow nasal cannula. A bedside chest X-ray reveals bilateral pulmonary infiltrates, raising suspicion for acute respiratory distress syndrome (ARDS). This development necessitates immediate escalation of care, including consideration for intubation and mechanical ventilation to ensure adequate oxygenation.

Further complicating the picture, a repeat set of laboratory tests indicates a significant drop in hemoglobin to 6.8 g/dL, suggesting ongoing internal bleeding, possibly exacerbated by the retroperitoneal hematoma. In addition to the declining hemoglobin, the patient's renal function shows deterioration, with serum creatinine rising to 2.3 mg/dL, indicating potential acute kidney injury likely secondary to hypoperfusion and possible rhabdomyolysis due to muscle breakdown from prolonged immobility. The nephrology team is consulted to evaluate the need for renal support or potential dialysis, while also considering the implications of fluid management in the context of his respiratory status.

As the team convenes to reassess the patient's management plan, the urgency of addressing the retroperitoneal hematoma becomes more pronounced, but the surgical risk remains high given the ongoing coagulopathy and multi-organ involvement. The critical care team must now prioritize stabilizing the patient's respiratory and renal functions while maintaining hemodynamic stability through the judicious use of vasopressors and continued transfusions. This complex interplay of systems failure demands a coordinated, multidisciplinary approach, with the need for swift decision-making to prevent further deterioration and optimize the patient's chance of recovery.

Section 5

As the critical care team swiftly moves to address the patient's acute respiratory distress, a series of interventions are implemented to stabilize his condition. The decision to proceed with intubation and mechanical ventilation is made, given the patient's deteriorating respiratory status and persistently low oxygen saturation levels despite high-flow nasal cannula support. The intubation is successfully performed, and the patient is placed on a lung-protective ventilation strategy. Ventilator settings are adjusted to optimize oxygenation and minimize the risk of ventilator-induced lung injury, with an initial FiO2 of 100% and positive end-expiratory pressure (PEEP) set at 10 cm H2O.

Meanwhile, the nephrology team evaluates the patient for renal support therapy. The rising serum creatinine and oliguria indicate worsening acute kidney injury. The decision is made to initiate continuous renal replacement therapy (CRRT) to manage fluid overload, maintain electrolyte balance, and support renal function without exacerbating the patient's respiratory distress. The CRRT is carefully titrated to balance the need for aggressive fluid removal with the risk of hemodynamic instability.

Throughout these interventions, the patient's hemodynamic status remains precarious. Blood pressure is supported with norepinephrine, but persistent bleeding from the suspected retroperitoneal hematoma complicates fluid resuscitation efforts. The hematology team intensifies factor VIII replacement therapy to address the coagulopathy, while surgical consultants evaluate the risk-benefit ratio of potential intervention on the hematoma. As the medical team navigates these challenges, they remain vigilant for signs of further complications such as sepsis or disseminated intravascular coagulation (DIC), which could further complicate this already critical clinical picture. Despite these efforts, the patient's condition remains tenuous, highlighting the need for ongoing, dynamic reassessment and adaptation of the treatment plan.